Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly
Data up to Jan 2025
Total Citations Per Year
Abstract
References (19)
Clinical Applications of Research on Angiogenesis
1995 • 2,300 citations
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.
2000 • 1,536 citations
Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth
1990 • 1,308 citations
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
2000 • 1,159 citations
Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.
1993 • 1,086 citations
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
1999 • 990 citations
Tumor angiogenesis: past, present and the near future
2000 • 973 citations
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation.
1999 • 866 citations
The microtubule-affecting drug paclitaxel has antiangiogenic activity.
1996 • 643 citations
Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibitors 2-methoxyestradiol and taxol.
1997 • 525 citations
Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene
1990 • 452 citations
Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti‐cancer therapeutic agents
1991 • 441 citations
The Ras superfamily of GTPases 1
1996 • 269 citations
A Novel, Microcarrier-Based in Vitro Assay for Rapid and Reliable Quantification of Three-Dimensional Cell Migration and Angiogenesis
1995 • 244 citations
‘Accidental’ anti-angiogenic drugs
2000 • 181 citations
Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: Evidence for a vascular mechanism
1991 • 175 citations
Paclitaxel (Taxol): An Inhibitor of Angiogenesis in a Highly Vascularized Transgenic Breast Cancer
1999 • 169 citations
Selective inhibition of endothelial cell proliferation by fumagillin is not due to differential expression of methionine aminopeptidases
2000 • 95 citations
Antiangiogenic chemotherapeutic agents.
2000 • 40 citations